White papers published using the Sorcerer Colony Counter
Sorcerer is used by research institutes and other organisations all over the world for cutting-edge research into a
wide range of applications. Below is just a small selection of white papers publised using the Sorcerer colony counter
to analyse samples.
Critical Roles of Complement and Antibodies in Host Defense Mechanisms against Neisseria meningitidis as Revealed by Human Complement Genetic Deficiencies
(2010) B.C. Hellerud et al, Am. Soc. Microb. 78(2):802-809
Selection and Characterization of Hepatitis C Virus Replicons Dually Resistant to the Polymerase and Protease Inhibitors HCV-796 and Boceprevir (SCH 503034)
(2009) M. Flint et al, Antim. Agents & Chemo. 53(2):401-411
Survey, laboratory and statistical methods for the BSAC Resistance Surveillance Programmes
(2008) R. Reynolds et al, J. Antim. Chemo. 62(2):15-28
Immunogenicity of Fractional Doses of Tetravalent A/C/Y/W135 Meningococcal Polysaccharide Vaccine: Results from a Randomized Non-Inferiority Controlled Trial in Uganda
(2008) P.J. Guerin et al, PLoS Negl Trop Dis 2(12):342
Lysophosphatidic acid receptor subtype-specific regulation of human oral fibroblast healing responses
(2008) D.R. Cerutis et al, FASEB J. 22(1):805-810
Evaluation of the genotoxic potential of the natural neurotoxin Tetrodotoxin (TTX) in a battery of in vitro and in vivo genotoxicity assays
(2007) A. Guzmán et al, Mut. Res. 634(1-2):14-24
In vitro models of TGF-beta-induced fibrosis suitable for high-throughput screening of antifibrotic agents
(2007) Q. Xu et al, Am. J. Physiol. 293(1):14-24
Blood pressure cuffs: friend or foe
(2007) N. Walker et al, J. Hosp. Infect. 63(2):167-169
Immunogenicity and Safety of a Combination of Two Serogroup B Meningococcal Outer Membrane Vesicle Vaccines
(2007) S. Sandbu et al, Clin. Vacc. Immun. 14(9):1062-1069
Constitutively active receptor tyrosine kinases as oncogenes in preclinical models for cancer therapeutics
(2006) K.A. Kellar et al, Mol. Cancer Ther. 5(6):1571
Antioxidant and antigenotoxic activities of Angelica keiskei, Oenanthe javanica and Brassica oleracea in the Salmonella mutagenicity assay and in HCT116 human colon cancer cells
(2006) D. Kwon et al, BioFactors 26(4):231-244
Validation of the serum bactericidal assay for measurement of functional antibodies against group B meningococci associated with vaccine trials
(2005) D. Martin et al, Vaccine 23(17-18):2218-2221
Malignant transformation of wild-type but not plasminogen activator inhibitor-1 gene-deficient fibroblasts decreases cellular sensitivity to chemotherapy-mediated apoptosis
(2005) U. Lademann et al, Euro. J. Cancer 41(7):1095-1100
Phenotypic variability of Pseudomonas aeruginosa in sputa from patients with acute infective exacerbation of cystic fibrosis and its impact on the validity of antimicrobial susceptibility testing
(2005) J.E. Foweraker et al, Antim. Chemo. 55(6):921-927
Approach to Validating an Opsonophagocytic Assay for Streptococcus pneumoniae
(2005) B.T. Hu et al, Clin. Diag. Lab. Imm. 12(2):287-295
TIMP-1 gene deficiency increases tumour cell sensitivity to chemotherapy-induced apoptosis
(2005) M.L. Davidsen et al, Brit. J. Cancer 55(6):921-927
|
